Focal takotsubo cardiomyopathy with high-dose interleukin-2 therapy for malignant melanoma

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 12, Issue 12, 2014, Pages 1666-1670

  Damodaran, Senthil ^a   Mrozek, Ewa ^a   Liebner, David ^a   Kendra, Kari ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; B RAF KINASE; HEMOGLOBIN; INTERLEUKIN 2; LEVOTHYROXINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METOPROLOL; ZOLPIDEM;

ADULT; AKINESIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CASE REPORT; CONTRAST ENHANCEMENT; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAM; EXERCISE TEST; FATIGUE; FEMALE; FLU LIKE SYNDROME; FOOT EDEMA; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICULOGRAPHY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERALGESIA; HYPOKINESIA; HYPOTENSION; LEUKOCYTE COUNT; MAINTENANCE THERAPY; METASTATIC MELANOMA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MYOCARDIAL PERFUSION IMAGING; NAUSEA; NEUTROPENIA; NEUTROPHIL COUNT; POSTMENOPAUSE; REPEAT PROCEDURE; RIGOR; SENTINEL LYMPH NODE BIOPSY; T WAVE INVERSION; TAKOTSUBO CARDIOMYOPATHY; THORAX PAIN; THROMBOCYTE COUNT; TREATMENT DURATION; TRICUSPID VALVE REGURGITATION; TUMOR BIOPSY; TUMOR INVASION; WIDE EXCISION; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMPLICATION; DOSE RESPONSE; IMMUNOTHERAPY; MELANOMA; METASTASIS; PATHOLOGY;

DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; TAKOTSUBO CARDIOMYOPATHY;

EID: 84918774206     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2014.0168     Document Type: Article

References (20)

1. Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation 2008; 118: 397-409.
2. Gianni M, Dentali F, Grandi AM, et al. Apical ballooning syndrome or takotsubo cardiomyopathy: A systematic review. Eur Heart J 2006; 27: 1523-1529.
3. Wickboldt N, Pache JC, Dietrich PY, et al. Takotsubo syndrome secondary to adrenal adenocarcinoma: Cortisol as a possible culprit. Am J Respir Crit Care Med 2012; 186: 1061-1062.
4. Richard C. Stress-related cardiomyopathies. Ann Intensive Care 2011; 1: 39.
5. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2007; 50: E1-e157.
6. Ogura R, Hiasa Y, Takahashi T, et al. Specific findings of the standard 12-lead ECG in patients with 'Takotsubo' cardiomyopathy: Comparison with the findings of acute anterior myocardial infarction. Circ J 2003; 67: 687-690.
7. Bybee KA, Kara T, Prasad A, et al. Systematic review: Transient left ventricular apical ballooning: A syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004; 141: 858-865.
8. Atkins MB, Lotze MT, Dutcher JP, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 1999; 17: 2105-2116.
9. Yeh ET, Tong AT, Lenihan DJ, et al. Cardiovascular complications of cancer therapy: Diagnosis, pathogenesis, and management. Circulation 2004; 109: 3122-3131.
10. White RL Jr, Schwartzentruber DJ, Guleria A, et al. Cardiopulmonary toxicity of treatment with high dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal cell carcinoma. Cancer 1994; 74: 3212-3222.
11. Thavendiranathan P, Verhaert D, Kendra KL, Raman SV. Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma. Br J Radiol 2011; 84: E99-e102.
12. Ognibene FP, Rosenberg SA, Lotze M, et al. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. Chest 1988; 94: 750-754.
13. Beck AC, Ward JH, Hammond EH, et al. Cardiomyopathy associated with high-dose interleukin-2 therapy. West J Med 1991; 155: 293-296.
14. Goel M, Flaherty L, Lavine S, Redman BG. Reversible cardiomyopathy after high-dose interleukin-2 therapy. J Immunother (1991) 1992; 11: 225-229.
15. Khakoo AY, Halushka MK, Rame JE, et al. Reversible cardiomyopathy caused by administration of interferon alpha. Nat Clin Pract Cardiovasc Med 2005; 2: 53-57.
16. Kobayashi N, Hata N, Yokoyama S, et al. A case of Takotsubo cardiomyopathy during 5-fluorouracil treatment for rectal adenocarcinoma. J Nippon Med Sch 2009; 76: 27-33.
17. Ozturk MA, Ozveren O, Cinar V, et al. Takotsubo syndrome: An underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction. Blood Coagul Fibrinolysis 2013; 24: 90-94.
18. Grunwald MR, Howie L, Diaz LA Jr. Takotsubo cardiomyopathy and fluorouracil: Case report and review of the literature. J Clin Oncol 2012; 30: E11-4.
19. Kepez A, Yesildag O, Erdogan O, Aktas B. Takotsubo cardiomyopathy in a patient with lung adenocarcinoma. Heart Views 2012; 13: 107-110.
20. Numico G, Sicuro M, Silvestris N, et al. Takotsubo syndrome in a patient treated with sunitinib for renal cancer. J Clin Oncol 2012; 30: E218-220.